AVITA Medical, Inc. business relationships
Companies named in AVITA Medical, Inc.’s 10-K filed 2026-02-12, and public companies whose annual reports name AVITA Medical, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 71 / 100 Top 1% in its category
- Agent readiness
- 30 / 100
- AI adoption
- 0 / 100
Named in AVITA Medical, Inc.’s annual report 2
“In January 2024, we entered into an exclusive multi-year distribution agreement with Stedical Scientific, Inc. ("Stedical") to market, sell, and distribute PermeaDerm, a biosynthetic wound matrix in the United States ("U.S.").” SEC filing
“In addition, in the United States, we hold the rights to manufacture and exclusively market, sell, and distribute PermeaDerm ® , a biosynthetic wound matrix, under the terms of exclusive multi-year distribution and contract manufacturing agreements with Stedical Scientific, Inc. ("Stedical").” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.